The Potential of IK as A Drug Target Or Biomarker (G3550)

Target Name: IK

NCBI ID: G3550

Content of Review Report on IK Target / Biomarker

The Potential of IK as A Drug Target Or Biomarker

IK (Immunoglobulin K) is a protein that is found in the blood of humans and other animals. It is a type of antibody that is made by the immune system to help fight off infections and other harmful substances that enter the body.

IK has been studied extensively over the years, and there is a lot of interest in it as a potential drug target or biomarker. This is because IK is involved in many different processes in the immune system, and it is thought to play a key role in protecting the body against a wide range of threats.

One of the things that makes IK an interesting target for a drug is its ability to interact with a variety of different molecules. This means that it is possible to use IK as a drug in a way that specifically targets its interactions with certain molecules, rather than just treating the symptoms of an underlying disease.

IK has also been shown to be involved in a number of different signaling pathways in the immune system. This means that it is possible to use IK as a drug by interfering with these signaling pathways, which could lead to a range of potential benefits.

Another potential advantage of IK as a drug target is its relatively simple structure. This makes it easier to understand how the body uses it and how it could be targeted by a drug.

In addition to its potential as a drug target, IK has also been shown to be a potential biomarker. This means that it can be used as a diagnostic tool to help doctors diagnose and treat diseases.

IK has been shown to be involved in a wide range of different immune responses, including the fight against infections, cancer, and other diseases. This makes it an important candidate as a biomarker for a variety of different diseases.

Overall, IK is an interesting protein that has a lot of potential as a drug target or biomarker. Its ability to interact with a variety of different molecules and its involvement in a range of different signaling pathways in the immune system make it an attractive candidate for both of these uses. Further research is needed to fully understand its potential and to develop safe and effective drugs or biomarkers for it.

Protein Name: IK Cytokine

Functions: Involved in pre-mRNA splicing as a component of the spliceosome (PubMed:28781166). Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species (Probable). Required for normal mitotic cell cycle progression (PubMed:22351768, PubMed:24252166). Recruits MAD1L1 and MAD2L1 to kinetochores, and is required to trigger the spindle assembly checkpoint (PubMed:22351768). Required for normal accumulation of SMU1 (PubMed:24945353)

The "IK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets